Ligandrol is an oral non-steroidal drug that produces positive results similar to the effects of taking steroids. The active agent of the drug provides a selective effect – it stimulates anabolic growth and increases bone strength instead of affecting the prostate gland.
The main positive property of Ligandrol is that it does not provoke an increase in the concentration of estrogen and cortisol. In addition, due to its selective effects, the drug makes it possible to achieve pronounced anabolic effects with minimal androgenic effects. Apoxar LGD-4033 has a 10:1 ratio of anabolic to androgenic index, while most steroid substances have a 1:1 ratio. The positive properties of Apoxar LGD-4033 include:
• selective binding to androgen receptors;
• increased muscle mass;
• improved muscle definition;
• improved endurance;
• stimulated reduction in body fat;
• increased activity of muscle fibers;
• an anti-catabolic effect, which allows users to retain muscle volumes during cutting;
• strengthened bone tissues;
• accelerated muscle recovery;
• normalized blood circulation;
• no fluid retention in tissues;
• no toxic effect on the liver;
• minimal side reactions;
• no tolerance of the body, no effect on the concentration of the prostatic specific antigen (PSA).